Olivia Brayer
Stock Analyst at Cantor Fitzgerald
(1.06)
# 2074
Out of 5,370 analysts
105
Total ratings
45.00%
Success rate
2.72%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VRNA Verona Pharma | Maintains: Overweight | 90 100 | 92.58 | 8.01% | 1 | Jun 11, 2025 | |
UTHR United Therapeutics | Initiates Coverage On: Overweight | 405 | 288.31 | 40.47% | 1 | Jun 2, 2025 | |
VNDA Vanda Pharmaceutical... | Assumes: Overweight | 13 | 4.57 | 184.46% | 1 | May 14, 2025 | |
BMRN Biomarin Pharmaceuti... | Reiterates: Overweight | 90 90 | 56.19 | 60.17% | 15 | Feb 20, 2025 | |
VRTX Vertex Pharmaceutica... | Reiterates: Overweight | 480 480 | 450.66 | 6.51% | 22 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 55 | 48.55 | 13.29% | 9 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 80 80 | 110.72 | -27.75% | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1015 1015 | 522.29 | 94.34% | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 295.12 | 37.23% | 2 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 220 220 | 308.78 | -28.75% | 23 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 8.13 | 23% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 3.81 | 70.6% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 41.66 | 72.83% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 21 | n/a | n/a | 2 | Feb 23, 2023 |